Skip to content
 
Search

Latest Stories

India's Serum Institute seeks emergency approval for AstraZeneca's Covid-19 vaccine

Pramod Thomas
By Pramod ThomasDec 07, 2020
Pramod Thomas
Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
See Full Bio
Follow:

INDIA's Serum Institute has sought approval for emergency use of AstraZeneca Plc's Covid-19 vaccine in the country, its chief executive officer said on Monday(7).

Serum Institute is the world's largest vaccine producer by volume.

The UK pharmaceutical giant is chasing rivals Pfizer Inc and Moderna Inc with a vaccine that has less stringent storage requirements and is expected to be easier to distribute and faster to scale up in production than others.

But it is also facing queries from scientists over its trial data, which showed a 1.5 dose regimen delivered more than 90 per cent efficacy and a full two-dose regimen just 62 per cent, both administered over two stages.

Astra said two weeks ago that it could launch an additional trial to evaluate the lower dose regimen, but Serum Institute has said it would continue to test only the two full doses as it would delay trials.

Serum Institute, seeking to deliver supplies for a domestic coronavirus outbreak that is the world's second biggest, has said an emergency use approval could preface a full rollout by February or March.

Serum Institute CEO Adar Poonawalla tweeted that the move to apply for emergency use "will save countless lives," but did not give any other details.

AstraZeneca's vaccine, called "Covishield" by Serum Institute, can be stored at two to eight degrees Celsius and distributed more easily in India, which lacks cold chain capabilities that the vaccine developed by Pfizer requires.

Poonawalla has said the company will first focus on supplying the vaccine in India before distributing it to other countries, pricing it at Rs 1,000 per dose ($13.50) for private markets.

Governments signing large supply deals will likely buy it at lower prices. In Europe, AstraZeneca has pledged to supply 300 million doses of the vaccine for around £685 million.

Over the weekend, a top Indian government health adviser said in a TV interview that Pfizer had applied for an emergency use authorization for its vaccine in the country.

An effective vaccine is increasingly being seen critical by governments as the only way to end a pandemic that has taken more than a million lives around the world.

Britain and some other nations have pressed on with plans to roll out the AstraZeneca vaccine, while the Philippines and Thailand secured millions of doses, giving the shot a vote of confidence after experts raised questions about trial data.

serum institute of indiaindia coronavirus

Related News

crypto
UK

Two jailed over £1.5m crypto investment scam

Bengaluru youth train at Spurs
Football

Bengaluru youth train at Spurs as part of development partnership

What problems does business analytics solve?
Sponsored Feature

What problems does business analytics solve?

More For You

Human brain continues forming neurons

Neurogenesis, the process by which new neurons form in the brain

iStock

Human brain continues forming neurons well into old age, study finds

Key points

  • New neurons continue forming in the brain’s hippocampus into old age
  • Study confirms presence of neural progenitor cells in adults
  • DNA carbon dating and single-nucleus RNA sequencing were used
  • Research shows variation in neuron production between individuals
  • Findings could aid treatments for neurodegenerative and psychiatric disorders

Human brain shows ongoing neuron formation into older age

A new study has confirmed that the human brain continues to produce new nerve cells well into late adulthood, challenging previous assumptions about age-related decline in neurogenesis. The findings, published in the journal Science, provide fresh insight into how adaptable the brain remains over a lifetime.

Neurogenesis, the process by which new neurons form in the brain, is known to occur in the hippocampus — a region involved in memory. While previous research has suggested that this process continues throughout life, there has been limited concrete evidence of the presence of neural progenitor cells in the adult brain.

Keep ReadingShow less
Kent County Show 2025

Sophie, Duchess of Edinburgh, who grew up in Brenchley

Getty Images

Kent County Show opens with royal visit from Duchess of Edinburgh

Key points:

  • Day one of the Kent County Show begins at Detling Showground near Maidstone
  • The Duchess of Edinburgh visits the event for the first time in 16 years
  • Organisers expect up to 70,000 visitors over the weekend
  • Farming and rural life are at the centre of the three-day programme
  • Highlights include live camel racing, equine sports, livestock displays and more

Kent County Show opens with royal visit

The Kent County Show returned to Detling near Maidstone on Friday, marking the start of a major three-day celebration of farming, food, and rural living. The event opened with a special visit from the Duchess of Edinburgh, who is attending for the first time in 16 years.

Sophie, Duchess of Edinburgh, who grew up in Brenchley near Tunbridge Wells and serves as patron of the Association of Show and Agricultural Organisations (ASAO), met with farmers, equine exhibitors, and local businesses on her tour of the showground.

Keep ReadingShow less
Sri Aurobindo

Heehs’s biography is grounded in extensive archival research across France, England, India and Israel

AMG

Sri Aurobindo and the rise of the Asian century

Dinesh Sharma

My friend and colleague, the American historian Peter Heehs, who has lived in Pondicherry, India, for decades, recently published a compelling new biography, The Mother: A Life of Sri Aurobindo’s Collaborator (2025). Heehs previously authored The Lives of Sri Aurobindo (2008), which remains one of the most balanced and scholarly accounts of Aurobindo’s life.

According to Heehs, most previous biographies of the Mother were written for devotees and relied on secondary sources, often presenting her as a divine incarnation without critical engagement. “Such biographies are fine for those who see the Mother as a divine being,” Heehs said, “but they can be off-putting for readers who simply want to understand her life – as an artist, writer, spiritual teacher, and founder of the Ashram and Auroville.”

Keep ReadingShow less
Black women cancer risk

Serious public health challenges in the decades ahead

iStock

Study warns of rising uterine cancer rates, with Black women hardest hit

Key points

  • Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
  • Black women are expected to experience the highest increase in incidence-based mortality.
  • A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
  • Researchers stress the urgent need for improved prevention and early detection strategies.

Sharp increase in uterine cancer predicted over next three decades

Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.

This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.

Keep ReadingShow less
Tesco Scotch Egg recall

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs

Tesco

Tesco recalls Wall’s Scotch Eggs over salmonella contamination

Key points

  • Tesco and the Food Standards Agency (FSA) have issued an urgent recall for Wall’s Scotch Eggs.
  • Salmonella contamination has been confirmed in two batches with a use-by date of July 2, 2025.
  • Customers are advised not to eat the affected items and return them to any Tesco store for a full refund.
  • No other Wall’s products are affected by this recall.

Wall’s Scotch Eggs recalled due to salmonella risk

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs after salmonella contamination was confirmed. The Food Standards Agency (FSA) supported the decision and has advised customers to check their kitchens and dispose of or return the products immediately.

The recall applies specifically to Wall’s 2 Classic Scotch Eggs 226g and Wall’s The Classic Scotch Egg 113g, both with a use-by date of 2 July 2025. Customers who purchased either product are urged not to consume them due to the potential health risk.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc